The trajectory of palliative care costs over the last 5 months of life: a Canadian longitudinal study.

Palliat Med

School of Social Work, Pavillon Charles-De Koninck, Laval University, Quebec City, QC, Canada, Laval University Cancer Research Center, Quebec City, QC, Canada.

Published: September 2010

Objective: This study aimed to highlight the trajectory of palliative care costs over the last five months of life in five urban centres across Canada.

Subjects: The study sample was comprised of 160 terminally ill patients and their main informal caregivers.

Research Design: A first interview took place in the patient's home, and subsequent follow-up interviews were conducted by telephone at two week intervals until the patient's passing.

Measures: Participants were asked to provide information on the goods and services they used related to the patients' health condition, and on informal caregiving time.

Results: The overall costs of care gradually increased from the fifth to the last month of the patients' life. A large part of this cost increase was attributable to inpatient care. Among outpatient care costs the largest increase was observed for home care. Informal care costs were particularly high over the last 3 months of life.

Conclusions: The knowledge gained from this study would be useful to policy makers when developing policies that could help families caring for a terminally ill loved one at home.

Download full-text PDF

Source
http://dx.doi.org/10.1177/0269216310368453DOI Listing

Publication Analysis

Top Keywords

care costs
16
trajectory palliative
8
palliative care
8
costs months
8
months life
8
terminally ill
8
care
7
costs
5
life canadian
4
canadian longitudinal
4

Similar Publications

Purpose: Improvements in the treatment of advanced cancer have increased life expectancy but have also increased the costs to healthcare systems, patients and their families. A systematic review is needed to summarize research work on the cost of cancer. The primary objective was to describe the characteristics and methodology of studies investigating the cost of cancer during the palliative phase.

View Article and Find Full Text PDF

Understanding the PrEP Care Continuum for Adults: Health Care Providers' Perspectives on Barriers, Facilitators, and Missed Opportunities.

AIDS Patient Care STDS

January 2025

Division of Epidemiology, Department of Public Health Science, School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, New York, USA.

Pre-exposure prophylaxis (PrEP) is an effective strategy in reducing HIV transmission, yet its uptake remains suboptimal. Health care providers play a vital role in facilitating PrEP access and care. This qualitative study explores health care providers' perspectives on the oral PrEP care continuum for adults, emphasizing barriers, facilitators, and missed opportunities in PrEP implementation.

View Article and Find Full Text PDF

Long-acting injectables (LAIs) for HIV prevention and treatment could dramatically improve health outcomes and health equity for people with HIV and those who could benefit from pre-exposure prophylaxis. Despite widespread acceptability and demand by providers and potential users of LAIs, implementation has been extremely limited since the introduction of cabotegravir/rilpivirine, the first LAI for HIV treatment, in January 2021, and long-acting cabotegravir, the first LAI for HIV prevention, in December 2021. We report results of a provider survey, conducted by the HIV Medicine Association, which identified LAI implementation barriers related to health insurance processes, staffing and administrative support, drug costs and acquisition, and access for individuals who are uninsured.

View Article and Find Full Text PDF

Background: disease-related malnutrition (DRM) affects 30-50 % of hospitalized patients and is often underdiagnosed, increasing risks of complications and healthcare costs. Traditional DRM detection has relied on manual methods that lack accuracy and efficiency.

Objective: this narrative review explores how artificial intelligence (AI), specifically machine learning (ML) and deep learning (DL), can transform the prediction and management of DRM in clinical settings.

View Article and Find Full Text PDF

New drugs for acute kidney injury.

J Intensive Med

January 2025

Department of Anesthesia and Perioperative Care, Division of Critical Care Medicine, UCSF, San Francisco, CA, USA.

Acute kidney injury (AKI) presents a significant challenge in the management of critically ill patients, as it is associated with increased mortality, prolonged hospital stays, and increased healthcare costs. In certain conditions, such as during sepsis or after cardiac surgery, AKI is one of the most frequent complications, affecting 30%-50% of patients. Over time, even after the resolution of AKI, it can evolve into chronic kidney disease, a leading global cause of mortality, and cardiovascular complications.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!